乐普生物-B拟推十年期限制性股份单位计划

Group 1 - The core focus of the article is on the corporate governance of Lepu Biopharma-B (02157.HK), highlighting a proposed ten-year restricted share unit plan aimed at incentivizing and retaining employees [1] - The plan is set to be discussed at the second extraordinary general meeting scheduled for December 18, 2025 [1] - The maximum number of shares to be granted under this plan is capped at 5% of the total issued shares as of the adoption date [1]